Related Experiment Video
Updated: Aug 5, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
ECG Criteria for Left Ventricular Hypertrophy in Hypertensive Black Africans: Insights from the coArtHA Trial
Annina S Vischer1,2, Valeriya Nemtsova1, Blaise Lukau3
1Medical Outpatient Department and Hypertension Centre, ESH Hypertension Centre of Excellence, University Hospital Basel, Basel, Switzerland.
Insights
Electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) showed moderate accuracy in Black African adults with hypertension. Cornell voltage product measures performed best, but population-specific evaluations are needed for optimal diagnosis.
Area of Science:
- Cardiology
- Medical Diagnostics
- Public Health
Background:
- Established electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) are primarily based on non-African populations.
- Their accuracy in Black African adults with untreated hypertension is not well-established.
Purpose of the Study:
- To assess the diagnostic performance of existing ECG-LVH criteria against echocardiography-derived left ventricular mass index (LVMI).
- To evaluate these criteria in Black African adults with untreated, uncomplicated hypertension within the coArtHA trial.
Main Methods:
- Included 1,125 participants from Tanzania and Lesotho undergoing baseline ECG and focused transthoracic echocardiography (fTTE).
- Left ventricular hypertrophy (LVH) defined by LVMI thresholds (women: >95 g/m², men: >115 g/m²).
- Diagnostic performance evaluated using correlation, sensitivity, specificity, ROC, AUROC, and PRC analyses.
Main Results:
- Echocardiographic LVH detected in 5% of participants.
- Cornell voltage product (adjusted for sex) showed the strongest correlation with LVMI (rho=0.37, p<0.001).
- Cornell voltage product-based criteria yielded the most consistent performance (AUROC ~0.76), with 64% sensitivity and 80% specificity at established cut-offs. Other criteria showed limited accuracy.
Conclusions:
- ECG criteria demonstrated moderate association with LVMI in this cohort.
- Cornell voltage product-based measures showed the most consistent diagnostic performance among evaluated ECG criteria.
- Findings highlight the need for population-specific validation of ECG criteria for LVH in African populations, considering cut-off selection and clinical context.
Background:
Electrocardiographic (ECG) criteria for detecting left ventricular hypertrophy (LVH) have largely been derived from non-African populations. Their diagnostic performance in Black African adults with untreated hypertension remains uncertain.
Objective:
To evaluate the diagnostic performance of established ECG-LVH criteria compared with echocardiographically assessed left ventricular mass index (LVMI) in Black African adults with untreated, uncomplicated hypertension enrolled in the coArtHA trial.
Methods:
In this subanalysis, we included 1,125 participants from rural Tanzania and Lesotho who underwent baseline 12-lead ECG and focused transthoracic echocardiography (fTTE). LVH was defined as LVMI > 95 g/m² in women, and >115 g/m² in men. Diagnostic performance of multiple ECG-LVH criteria was assessed using correlation analyses, sensitivity and specificity estimates, receiver-operating characteristic (ROC) analysis, including calculation of the area under the ROC curve (AUROC), and precision-recall curves (PRC).
Results:
Echocardiographic LVH was present in 56 (5%) participants. Across continuous ECG indices, Cornell voltage product adjusted by +0.8 mV in women showed the strongest association with LVMI (Spearman's rho = 0.37, p < 0.001). Among evaluated criteria, Cornell voltage product-based measures demonstrated the most consistent diagnostic performance across evaluated metrics, with an AUROC of approximately 0.76. Using established cut-off values, this criterion yielded a sensitivity of 64% and a specificity of 80%, whereas voltage-only criteria, including Multi-Ethnic Study of Atherosclerosis (MESA)- and Sokolow-Lyon-based indices, showed limited accuracy in this setting. Exploratory analyses of alternative cut-off values demonstrated the expected sensitivity-specificity trade-offs.
Conclusions:
In this cohort of hypertensive Black African adults, ECG criteria showed a moderate association with LVMI by echocardiography. Among established ECG criteria, Cornell voltage product-based measures demonstrated the most consistent diagnostic performance. Diagnostic characteristics were strongly influenced by cut-off selection and clinical context, underscoring the need for population-specific evaluation and external validation of ECG criteria for LVH in African settings.
Trial Registration:
Clinicaltrials.gov NCT04129840. Registered on October 17, 2019 (https://www.clinicaltrials.gov/).
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Hypertension II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Hypertension I: Introduction